Compound Monograph

Pimaric Acid

Terpenoids Diterpenes Natural (plant-derived)

Pimaric acid is a minor diterpene resin acid of pine and fir oleoresin and the parent of the pimarane class. Its pharmacological interest is narrow but real: it opens BK potassium channels, an activity its close relative abietic acid does not share at all.

Sources · 6

Where Does It Come From?

Pimaric Acid is a naturally occurring pimarane diterpene resin acid, found in Subalpine fir, Pine and 4 other sources. It is well tolerated orally (low toxicity).

Also found in
Gum rosin and tall-oil rosin Monograph coming soon
Japanese spikenard Monograph coming soon
Subalpine fir Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

Pimaric Acid at a Glance

Pimaric acid is one of the minor diterpene resin acids of pine and fir oleoresin, and the compound the whole pimarane class is named after. In rosin it sits well behind abietic acid: in softwood sawmill air the two were measured together at 0.6 and 7.2 µg/m³ respectively 5Reference 5Demers PA et al. · 2000ObservationalExposure to dust, resin acids, and monoterpenes in softwood lumber mills — cross-sectional exposure surveyView study →.

It has one distinct pharmacological identity, and it is a laboratory one. Pimaric acid opens large-conductance calcium-activated potassium (BK) channels, and it does so cleanly enough to be used as a research tool for the channel 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →. That single activity is what separates it from its far more abundant relative — because abietic acid, structurally almost identical, does nothing to BK channels at all 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →.

Why It Opens BK Channels and Abietic Acid Does Not

This is the interesting thing about the molecule. Nine closely related diterpenes were screened against BK channels expressed in HEK293 cells. Pimaric acid, isopimaric acid, sandaracoisopimaric acid and three dihydro derivatives all produced substantial membrane hyperpolarisation and opened the channel in the same 1–10 µM range. Abietic acid, sclareol and methyl pimarate had no effect at all 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →.

Pimaric acid does not change the channel’s unit conductance. It raises open probability by increasing sensitivity to both calcium and voltage, works from either side of the membrane, and acts on the BKα subunit — coexpressing β1 did not change the response. It is selective for BK over the small- and intermediate-conductance calcium-activated potassium channels 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →.

The authors made the point that carries: pimaric and abietic acid differ only very slightly in structure, yet one is a BK opener and the other is inert. The pimarane skeleton carries a vinyl group and a quaternary methyl at C-13 where the abietane carries an isopropyl group on an aromatic-adjacent ring — and that small difference is the whole activity. Anyone reasoning about “conifer resin acids” as a single pharmacological block is reasoning about the wrong unit.

Later work extended the profile beyond BK. Pimaric acid also shifts the voltage-activation of several voltage-gated KV1 and KV2.1 channels to lower potentials and slows their deactivation, with a phenylalanine in the S5 segment identified by mutagenesis as critical to the effect; KV4.3 was not affected 2Reference 2Sakamoto K et al. · 2017In vitroMolecular mechanisms underlying pimaric acid-induced modulation of voltage-gated K(+) channels — in vitro electrophysiologyView study →.

What It's Used For

Everything below is in vitro or in isolated animal tissue. Pimaric acid has no clinical literature.

A genuine, selective BK channel openerat 1–10 µM, acting on the α subunit by raising calcium and voltage sensitivity — and a useful negative control against abietic acid, which is inactive 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →.
The downstream effect is vasorelaxation, shown in rat pulmonary arterial smooth muscle, where it attenuates high-K⁺ and endothelin-1 vasoconstriction through BK opening and voltage-dependent calcium channel inhibition 3Reference 3Ishida M et al. · 2023AnimalPimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles — animal model (isolated tissue)View study →.
One vascular-remodelling finding from a different plant.Pimaric acid purified from Aralia cordata suppressed TNF-α-induced MMP-9 production and human aortic smooth-muscle migration via NF-κB and AP-1 4Reference 4Suh SJ et al. · 2012In vitroPimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1 — in vitroView study →.
Evidence by IndicationStrength of support · Beta

Mechanisms

Target / pathwayEffectRelevant to
BK (KCa1.1) α subunitopener — raises open probability via increased Ca²⁺ and voltage sensitivity; no change in conductance
BK channel openingvasorelaxation
KV1.1–KV1.6, KV2.1leftward shift in voltage activation, slowed deactivation; KV4.3 unaffected
channel pharmacology
Voltage-dependent Ca²⁺ channelsinhibited, lowering cytosolic Ca²⁺ in smooth muscle
vasorelaxation
NF-κB / AP-1 → MMP-9transcription suppressed; ERK, p38 and JNK activation blocked
smooth-muscle migration

Pharmacokinetics

None characterised. Pimaric acid has not been administered to a person or, so far as the indexed literature records, dosed systemically in an animal — the entire pharmacology is cell and isolated-tissue work at defined bath concentrations. No absorption, metabolism or half-life data exist.

Clinical Trials

No clinical trials. There is no development programme for pimaric acid; it functions as a pharmacological tool compound for BK channel research.

CompletedPlannedTerminatedPreclinical
None——BK/KV electrophysiology, isolated-vessel vasorelaxation, smooth-muscle migration

Last checked: September 2026.

Isolate vs. Plant Studies

Entirely isolate. Every result here used purified pimaric acid at a known bath concentration, and one of them used material purified from a plant — Aralia cordata — that is not a conifer at all 4Reference 4Suh SJ et al. · 2012In vitroPimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1 — in vitroView study →. Nothing has been shown for pine or fir resin, needle oil, or any preparation a person would encounter, and the concentrations that open BK channels are not concentrations a resin salve or a needle tea delivers.

The honest reading is that pimaric acid is a useful molecule that happens to occur in conifer resin, not an explanation for anything conifer resin does.

Its Role in Plants

Pimaric acid is part of the conifer oleoresin defence fraction — the sticky, non-volatile residue that seals wounds and deters bark beetles once the monoterpenes have evaporated. It shares its origin with abietic acid: both descend from geranylgeranyl diphosphate through the bifunctional diterpene cyclase abietadiene synthase 6Reference 6LaFever RE et al. · 1994In vitroDiterpenoid resin acid biosynthesis in conifers: enzymatic cyclization of geranylgeranyl pyrophosphate to abietadiene, the precursor of abietic acid — in vitro enzymologyView study →.

The relationship is closer than a shared enzyme. Mechanistic work on abietadiene synthase showed that the reaction proceeds through cryptic pimarenyl carbocation intermediates — the pimarane skeleton is a way-station on the route to the abietane one 7Reference 7Ravn MM et al. · 2002In vitroMechanism of abietadiene synthase catalysis: stereochemistry and stabilization of the cryptic pimarenyl carbocation intermediates — in vitro enzymologyView study →. Pimaric acid is, in that sense, what happens when the enzyme’s intermediate is captured rather than rearranged, which is a large part of why conifers make a family of resin acids instead of a single compound.

Prevalence in Nature

A Pinaceae resin acid, consistently present and consistently minor. The one quantified figure is airborne rather than in-tissue: in a British Columbia lumber mill processing spruce, lodgepole pine and subalpine fir, personal sampling gave a mean airborne pimaric acid of 0.6 µg/m³ against 7.2 µg/m³ for abietic acid — roughly a twelvefold difference in the same dust 5Reference 5Demers PA et al. · 2000ObservationalExposure to dust, resin acids, and monoterpenes in softwood lumber mills — cross-sectional exposure surveyView study →.

It also occurs outside the conifers. Japanese spikenard (Aralia cordata), an Araliaceae root used in East Asian herbal medicine, was the source used for the vascular smooth-muscle work 4Reference 4Suh SJ et al. · 2012In vitroPimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1 — in vitroView study →. The closely related 4-epi-pimaric acid is a separate molecule with its own antibacterial and anti-biofilm literature against oral pathogens — related, but not this compound 8Reference 8Ali F et al. · 2012In vitroAli F, Sangwan PL, Koul S, et al. (2012). 4-epi-Pimaric acid: a phytomolecule as a potent antibacterial and anti-biofilm agent for oral cavity pathogens — in vitro. Eur J Clin Microbiol Infect Dis. https://pubmed.ncbi.nlm.nih.gov/21594714/View study →.

Discovery & Synthesis

Pimaric acid belongs to the mid-twentieth-century era of rosin chemistry, when the individual resin acids were separated from one another for the first time. Dextropimaric acid was isolated in 1948, in the same work that described the new pimaric-type acid isodextropimaric acid 9Reference 9Harris GC · 1948Resin acids; the isolation of dextropimaric acid and a new pimaric-type acid, isodextropimaric acidView study → — the paper that gave the class its members. The name derives from the pimaric acids’ original identification in pine resin, and dextro- distinguishes the naturally occurring rotation.

There is no manufacturing route to speak of, because there is no demand for pure pimaric acid outside the laboratory. It is obtained by fractionating rosin. What industry does with rosin acids as a class — hydrogenation, disproportionation, esterification — is aimed at the abietic-type acids rather than this one.

Patents: not yet researched.

Toxicity & Safety

There is no toxicology package for pimaric acid. It has not been given to animals systemically, so acute, repeat-dose, genotoxicity and reproductive data simply do not exist — an absence, not a clearance.

Safety at a Glance
Low / no toxicity
  • No documented toxicity of its own, and it is a minor component of a material people have handled for centuries.
  • Colophony cross-reactivity applies to the material, not this molecule. Someone patch-test positive to rosin should treat pine and fir resin products with the same caution regardless of which resin acid is named; the sensitisers are oxidation products of the abietic-type acids 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →.
  • No safety data exist for an oral or systemic dose. Nothing here supports taking it.
Full Safety & Interactions Detail

What is not known. No acute or repeat-dose toxicity study, no genotoxicity assay, no reproductive-toxicity data and no drug-interaction work has been published for pimaric acid. The silence reflects the fact that nobody has developed it, not evidence of safety.

Contact allergy. Rosin allergy is real and common, but the allergens were traced to the oxidation products of abietic and dehydroabietic acid — 15-hydroperoxyabietic acid and the 13,14-epoxides — not to the pimarane acids 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →. Pimaric acid is nonetheless present in the same material, so a person allergic to colophony has no practical way to separate the two, and the sensible handling advice is about the resin, not the molecule. See abietic acid for that story in full.

Mechanistic caution. BK channel opening at micromolar concentrations is a genuine cardiovascular action in isolated tissue 1,3Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →Reference 3Ishida M et al. · 2023AnimalPimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles — animal model (isolated tissue)View study →. Because no systemic exposure has ever been characterised, there is no basis for judging whether ordinary contact with pine resin approaches those concentrations — but nothing suggests it does.

Dosage

There is no dose. Pimaric acid is not taken, and the only figures in the literature are bath concentrations in cell and tissue experiments, plus one airborne exposure measurement.

ContextFormFigure reported
BK channel activationbath concentration, HEK293 cells1–10 µM 1Reference 1Imaizumi Y et al. · 2002In vitroMolecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiologyView study →
Isolated pulmonary arterybath concentration, rat tissueMicromolar, BK activation plus VDCC inhibition 3Reference 3Ishida M et al. · 2023AnimalPimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles — animal model (isolated tissue)View study →
Softwood lumber mill airinhalable particulate0.6 µg/m³ mean airborne pimaric acid 5Reference 5Demers PA et al. · 2000ObservationalExposure to dust, resin acids, and monoterpenes in softwood lumber mills — cross-sectional exposure surveyView study →

These are experimental concentrations and an exposure measurement, not a personal recommendation.

References

  1. Imaizumi Y, Sakamoto K, Yamada A, et al. (2002). Molecular basis of pimarane compounds as novel activators of large-conductance Ca(2+)-activated K(+) channel alpha-subunit — in vitro electrophysiology. Mol Pharmacol. https://pubmed.ncbi.nlm.nih.gov/12237330/
  2. Sakamoto K, Suzuki Y, Yamamura H, et al. (2017). Molecular mechanisms underlying pimaric acid-induced modulation of voltage-gated K(+) channels — in vitro electrophysiology. J Pharmacol Sci. https://pubmed.ncbi.nlm.nih.gov/28391996/
  3. Ishida M, Yamamura A, Fujiwara M, et al. (2023). Pimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles — animal model (isolated tissue). J Pharmacol Sci. https://pubmed.ncbi.nlm.nih.gov/37640473/
  4. Suh SJ, Kwak CH, Chung TW, et al. (2012). Pimaric acid from Aralia cordata has an inhibitory effect on TNF-α-induced MMP-9 production and HASMC migration via down-regulated NF-κB and AP-1 — in vitro. Chem Biol Interact. https://pubmed.ncbi.nlm.nih.gov/22705379/
  5. Demers PA, Teschke K, Davies HW, et al. (2000). Exposure to dust, resin acids, and monoterpenes in softwood lumber mills — cross-sectional exposure survey. AIHAJ. https://pubmed.ncbi.nlm.nih.gov/10976682/
  6. LaFever RE, Vogel BS, Croteau R (1994). Diterpenoid resin acid biosynthesis in conifers: enzymatic cyclization of geranylgeranyl pyrophosphate to abietadiene, the precursor of abietic acid — in vitro enzymology. Arch Biochem Biophys. https://pubmed.ncbi.nlm.nih.gov/8053674/
  7. Ravn MM, Peters RJ, Coates RM, et al. (2002). Mechanism of abietadiene synthase catalysis: stereochemistry and stabilization of the cryptic pimarenyl carbocation intermediates — in vitro enzymology. J Am Chem Soc. https://pubmed.ncbi.nlm.nih.gov/12059223/
  8. Ali F, Sangwan PL, Koul S, et al. (2012). 4-epi-Pimaric acid: a phytomolecule as a potent antibacterial and anti-biofilm agent for oral cavity pathogens — in vitro. Eur J Clin Microbiol Infect Dis. https://pubmed.ncbi.nlm.nih.gov/21594714/
  9. Harris GC, Sanderson TF (1948). Resin acids; the isolation of dextropimaric acid and a new pimaric-type acid, isodextropimaric acid. J Am Chem Soc. https://pubmed.ncbi.nlm.nih.gov/18863801/